Skip to main content
. 2017 Apr 12;8(22):36664–36673. doi: 10.18632/oncotarget.17067

Figure 3. Correlation of anti-ENO1 level with CEA, and CYFRA 21-1 in sera from patients with NSCLC.

Figure 3

(A and B) show autoantibody level of anti-ENO1 has no correlation with CEA (A) and CYFRA 21-1 (B) in NSCLC patients. P: Spearman's test, R: Correlation coefficient in Spearman's test. (C): frequency/sensitivity of anti-ENO1, CEA, CYFRA 21-1 and their combination in NSCLC patients.